REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lek S.A. (Poland)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Secondary Activities: Automobile and Other Motor Vehicle Merchant Wholesalers | Motor Vehicle Supplies and New Parts Merchant Wholesalers | General Line Grocery Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Warehousing and Storage | Lessors of Real Estate | Packaging and Labeling Services
Full name: Lek S.A. Profile Updated: January 16, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Lek S.A. is based in Poland, with the head office in Strykow. It operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on November 16, 2001. Lek S.A. currently employs 904 (2020) people. From the latest financial highlights, Lek S.A. reported a net sales revenue drop of 16.34% in 2024. A negative growth of 21.88% was recorded in its total assets. The net profit margin of Lek S.A. increased by 0.6% in 2024.

Headquarters
Ul. Podlipie 16
Strykow; Lodzkie; Postal Code: 95-010

Contact Details: Purchase the Lek S.A. report to view the information.

Website: http://lek-sa.pl

Basic Information
Total Employees:
Purchase the Lek S.A. report to view the information.
Registered Capital:
Purchase the Lek S.A. report to view the information.
Financial Auditors:
Purchase the Lek S.A. report to view the information.
Incorporation Date:
November 16, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lek S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-16.34%▼
Total Operating Revenue
-16.26%▼
Operating Profit
-3.28%▼
EBITDA
-0.99%▼
Net Profit/Loss for the Period
3.77%▲
Total Assets
-21.88%▼
Total Equity
9.72%▲
Operating Profit Margin
0.58%▲
Net Profit Margin
0.6%▲
Return on Equity (ROE)
-0.51%▼
Quick Ratio
0.72%▲

Similar companies

Zaklady Farmaceutyczne "Polpharma" S.A.
 
"Roche Polska" Sp. z o.o.
Bayer Sp. z o.o.
 
Teva Operations Poland Sp. z o.o.
Adamed Pharma S.A.
 
Sanofi Sp. z o.o.
Centrala Farmaceutyczna "Cefarm" S.A.
 
Aflofarm Farmacja Polska Sp. z o.o.
"Usp Zdrowie" Sp. z o.o.
 
"Fresenius Kabi Polska" Sp. z o.o.

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo